<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03664999</url>
  </required_header>
  <id_info>
    <org_study_id>KDAR FN Brno 2018/9</org_study_id>
    <nct_id>NCT03664999</nct_id>
  </id_info>
  <brief_title>Serum Immunologic Markers Levels in During the Delivery</brief_title>
  <acronym>DIMDOED</acronym>
  <official_title>Dynamics of Serum Immunologic Markers Levels in During the Delivery and Possible Benefit for Obstetric Emergency Diagnostics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brno University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brno University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aim to describe dynamics of immunologic markers C1 inhibitor, C3, C4 during the
      delivery in order to improve early diagnostics of obstetric emergencies, especially with
      immune etiology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our prospective observational study will explore the differences between dynamics of the
      complement components C1 inhibitor, C1 inhibitor activity, C3, C4 during the labour in a
      group of women with physiologic pregnancy and in a group with a risk of complications
      (pre-eclampsia, HELLP syndrome, placenta praevia, placental abruption, IUGR, previous post
      partum hypotony).

      We will focus on women undergoing the Caesarean delivery. We will also measure D vitamin
      levels and ACE levels and search for some contexts.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 8, 2018</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in levels of total C1 inhibitor</measure>
    <time_frame>30 minutes before and 30 minutes after delivery</time_frame>
    <description>Chenge in levels of total C1 inhibitor</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in levels of CRP levels</measure>
    <time_frame>30 minutes before and 30 minutes after delivery</time_frame>
    <description>Change in levels of CRP levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in levels of D vitamin levels</measure>
    <time_frame>30 minutes before and 30 minutes after delivery</time_frame>
    <description>Change in levels of D vitamin levels and it's relationship to pre-eclampsia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in levels of ACE levels</measure>
    <time_frame>30 minutes before and 30 minutes after delivery</time_frame>
    <description>Change in levels of ACE levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of C1 inhibitor activity</measure>
    <time_frame>30 minutes before and 30 minutes after delivery</time_frame>
    <description>Change of C1 inhibitor activity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in levels of total C3</measure>
    <time_frame>30 minutes before and 30 minutes after delivery</time_frame>
    <description>Change in levels of total C3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in levels of total C4</measure>
    <time_frame>30 minutes before and 30 minutes after delivery</time_frame>
    <description>Change in levels of total C4</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">57</enrollment>
  <condition>Immunologic Markers</condition>
  <arm_group>
    <arm_group_label>Parturients physiologic pregnancy</arm_group_label>
    <description>Parturients undergoing caesarean delivery with physiologic pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Parturients with risk pregnancy</arm_group_label>
    <description>Parturients undergoing caesarean with risk of complications (pre-eclampsia, HELLP syndrom, placenta praevia, placental abruption, IUGR, previous post partum hypotony).</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>differences between dynamics of the complement components C1 inhibitor, C1 inhibitor activity, C3, C4 during the labour in a group of women with physiologic pregnancy and in a group with a risk of complications (pre-eclampsia, HELLP syndrome, placenta praevia, placental abruption, IUGR, previous post partum hypotony).</description>
    <arm_group_label>Parturients physiologic pregnancy</arm_group_label>
    <arm_group_label>Parturients with risk pregnancy</arm_group_label>
    <other_name>Blood sample</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Parturients indicated for caesarean section
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women undergoing the Caesarean delivery

          -  Signed informed consent

        Exclusion Criteria:

          -  Previous hepatitis or other hepatocyte damage
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Brno</name>
      <address>
        <city>Brno</city>
        <zip>62500</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 4, 2018</study_first_submitted>
  <study_first_submitted_qc>September 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2018</study_first_posted>
  <last_update_submitted>September 12, 2019</last_update_submitted>
  <last_update_submitted_qc>September 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brno University Hospital</investigator_affiliation>
    <investigator_full_name>Petr Štourač, MD</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

